Result of Fundraising

THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF XEROS TECHNOLOGY GROUP PLC IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO 596/ 2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS GIVEN TO THEM IN THE COMPANY'S ANNOUNCEMENT RELEASED AT 18:32 P.M. YESTERDAY.

Xeros Technology Group plc

("Xeros", the "Group" or the "Company")

Result of Fundraising

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, is pleased to announce that further to the Company's announcement released at 18:32 p.m. yesterday (the "Launch Announcement"), the ABB has closed and the Company has conditionally raised gross proceeds of approximately £3.0 million, through the successful Placing and Initial Subscription of 171,847,501 New Ordinary Shares in aggregate at the Issue Price of 1.75 pence per Ordinary Share.

In addition to the Placing and Initial Subscription, the Company is also seeking to raise up to an additional £2.0 million by way of the Follow-On Subscription and is also providing all shareholders with the opportunity to subscribe for an aggregate of up to £1.0 million by way of the Retail Offer, both at the Issue Price.

The Placing, Subscriptions and Retail Offer are conditional upon, inter alia, the passing of the Resolutions at the General Meeting, Admission and upon the Placing Agreement becoming unconditional in all respects. It is expected that Admission will occur, and that dealings in the New Ordinary Shares will become effective on 1 December 2025.

No part of the Placing or Initial Subscription is conditional on the Follow-On Subscription or Retail Offer proceeding or on any minimum take-up under the Follow-On Subscription or Retail Offer.

General Meeting and Shareholder Approval

For the New Ordinary Shares to be admitted to trading on AIM, Shareholder approval is required:

a) by way of ordinary resolution to give the Directors authority to allot such New Ordinary Shares and New Ordinary Shares to be issued on exercise of the Warrants; and

b) by way of a special resolution to disapply statutory pre-emption rights in respect of such New Ordinary Shares.

The authorities referred to above are in addition to the Company's existing general shareholder authorities to allot Ordinary Shares for cash on a non-pre-emptive basis.

In order to obtain the necessary shareholder approval, a General Meeting is to be held at the Company's offices at the offices of Squire Patton Boggs (UK) LLP at 60 London Wall London EC2M 5TP at 10:00 a.m. on 28 November 2025 at which the Resolutions will be proposed. A Circular containing a notice of General Meeting is expected to be sent to shareholders today. The shareholder Circular and notice of General Meeting will be made available on the Company's website at www.xerostech.com.

A copy of the Company's investor presentation in relation to this Transaction will be made available on the Company's investor relations website shortly.

Neil Austin, Alex Tristram and Dowgate Capital Limited are each a Related Party (as defined by the AIM Rules), and will be participating in the Fundraise as follows:

*Assuming full take up of the Follow-On Subscription and Retail Offer

The participation of the Director Subscribers in the Fundraise constitutes related party transactions within the meaning of the AIM Rules, by virtue of them each being Directors. The Directors (excluding the Director Subscribers) consider, having consulted with Cavendish (the Company's nominated adviser), that the terms of the Director Subscriptions in the Fundraise are fair and reasonable insofar as the Company's Shareholders are concerned.

The participation in the Placing of Dowgate Capital Limited constitutes a related party transaction by virtue of them being substantial shareholders in the Company. The Directors consider, having consulted with Cavendish (the Company's nominated adviser), that the terms of their participation in the Fundraising by Dowgate Capital Limited are fair and reasonable insofar as the Company's shareholders are concerned.

Kinetix Corporate Finance LLP, an entity owned and controlled by David Armfield, Non-Executive Director of the Company, has entered into an agreement with the Company to provide transaction support to the private placement of new share capital through the Adjuvo investor network. Kinetix Corporate Finance LLP will receive a success fee of 1.0 per cent. of any monies received by the Company in connection with the Subscriptions by Adjuvo investors. The maximum possible fee that could be payable to Kinetix Corporate Finance LLP is £37,500, assuming full up take of the Follow-on Subscription and the full amount of the Retail Offer is taken up by Adjuvo investors. The Directors (excluding David Armfield) consider, having consulted with Cavendish (the Company's nominated adviser), that the terms of the agreement with Kinetix Corporate Finance LLP are fair and reasonable insofar as the Company's shareholders are concerned.

Enquiries: